Keywords
Schizophrenia ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

346 Search results.

Eligibility Tobacco Smoking in Schizophrenic Patients NCT01979796

- 7/13/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Antismoking Effects of Electronic Cigarettes in Subjects With Schizophrenia and Their Potential Influence on Cognitive Functioning.; ODM derived from: https://clinicaltrials.gov/show/NCT01979796

Eligibility Schizophrenic Psychoses NCT02388607

- 7/7/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sustained Attention Abilities in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02388607

Eligibility Schizophrenia NCT02511509

- 7/7/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02511509

Eligibility Schizophrenia NCT02040883

- 7/6/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02040883

Eligibility Schizophrenia NCT02478827

- 7/6/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Trial of Cognitive Training in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02478827

Eligibility Schizophrenia NCT02435095

- 7/6/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Antipsychotic Induced Structural and Functional Brain Changes; ODM derived from: https://clinicaltrials.gov/show/NCT02435095

Eligibility Schizophrenia NCT02333487

- 7/6/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700; ODM derived from: https://clinicaltrials.gov/show/NCT02333487

Eligibility Schizophrenia NCT02320032

- 7/6/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02320032

Eligibility Schizophrenia NCT02205684

- 7/6/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Effects of Physical Activity in Psychosis; ODM derived from: https://clinicaltrials.gov/show/NCT02205684

Eligibility Schizophrenia NCT02086786

- 7/6/19 - 1 form, 2 itemgroups, 25 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02086786

Eligibility Schizophrenia NCT02054702

- 7/6/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT02054702

Eligibility Schizophrenia NCT02019329

- 7/5/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone; ODM derived from: https://clinicaltrials.gov/show/NCT02019329